Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.

Interleukin-8 (IL-8; CXCL8) is a cytokine of the CXC chemokine family that is involved in neutrophil recruitment and activation. In addition, IL-8 has been implicated in a wide variety of other processes, including angiogenesis and metastasis in lung cancer. Lung adenocarcinoma and muco-epidermoid carcinoma cells produce substantial amounts of IL-8, and express both CXCR1 and CXCR2 IL-8 receptors. We hypothesized that IL-8 stimulates proliferation of non-small cell lung cancer cells, involving transactivation of the epidermal growth factor receptor (EGFR). The EGFR plays a central role in regulating cell proliferation and it has been therefore implicated in lung cancer. Both EGFR ligands and transactivation of the receptor may lead to downstream signalling events, including mitogen-activated protein kinase (MAPK) activation. Transactivation of the EGFR has been shown to occur in response to ligands of various G-protein coupled receptors (GPCRs) and involves metalloproteinase-mediated release of membrane bound EGFR ligands. The aim of the present study was to investigate the effect of IL-8 on proliferation of lung adenocarcinoma and muco-epidermoid carcinoma cells, and to explore the mechanisms leading to this proliferation in two different non-small cell lung cancer cell lines (A549 and NCI-H292). In both NSCLC cell lines, we observed that IL-8 stimulates epithelial cell proliferation in a dose-dependent manner. The ability of IL-8 to increase cell proliferation was blocked both by an inhibitor of EGFR tyrosine kinase, by a specific anti-EGFR blocking antibody and by a panmetalloproteinase inhibitor. Similar results were obtained using the GPCR inhibitor pertussis toxin. Inhibition of the MAPK p42/44 (ERK1/2) also blocked the mitogenic effect of IL-8, while a p38 MAPK inhibitor did not affect IL-8-induced cell proliferation. These results suggest that IL-8 increases cell proliferation in NSCLC cell lines via transactivation of the EGFR and that this mechanism involves metalloproteinase activity.

[1]  R. Salgia,et al.  Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. , 2002, Cytokine & growth factor reviews.

[2]  D. Romberger,et al.  Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. , 1997, American journal of respiratory and critical care medicine.

[3]  Akira Yamauchi,et al.  The intratumoral expression of vascular endothelial growth factor and interleukin‐8 associated with angiogenesis in nonsmall cell lung carcinoma patients , 2001, Cancer.

[4]  T. Betsuyaku,et al.  Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema , 2002, Thorax.

[5]  B. H. Shah,et al.  The Protein Kinase C Inhibitor Go6976 [12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] Potentiates Agonist-Induced Mitogen-Activated Protein Kinase Activation through Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor , 2005, Molecular Pharmacology.

[6]  A. Flahault,et al.  Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. , 1998, The American journal of pathology.

[7]  L. Fabbri,et al.  COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma , 2004, Thorax.

[8]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[9]  D. Sheppard,et al.  Heparin-binding epidermal growth factor cleavage mediates zinc-induced epidermal growth factor receptor phosphorylation. , 2004, American journal of respiratory cell and molecular biology.

[10]  S. Lippman,et al.  Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  B. Wretlind,et al.  Mitogenic action of tumour necrosis factor-alpha and interleukin-8 on explants of human duodenal mucosa. , 2001, Cytokine.

[12]  K. Rabe,et al.  The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor 1 , 2003, The Journal of Immunology.

[13]  Carlos L Arteaga,et al.  ErbB-targeted therapeutic approaches in human cancer. , 2003, Experimental cell research.

[14]  P. Gibson,et al.  Interleukin-8 stimulates the migration of human colonic epithelial cells in vitro. , 1999 .

[15]  A. Yuan,et al.  Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. , 2000, American journal of respiratory and critical care medicine.

[16]  Ping Wang,et al.  Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization , 1998, Journal of cellular biochemistry.

[17]  P. Wipf,et al.  Induction of Cdc25B expression by epidermal growth factor and transforming growth factor-alpha. , 2004, Biochemical pharmacology.

[18]  R. Salgia,et al.  Chemokine Receptors CXCR-1/2 Activate Mitogen-activated Protein Kinase via the Epidermal Growth Factor Receptor in Ovarian Cancer Cells* , 2000, The Journal of Biological Chemistry.

[19]  K. Rabe,et al.  Human neutrophil defensins induce lung epithelial cell proliferation in vitro , 2002, Journal of leukocyte biology.

[20]  D. Proud,et al.  Effects of tumor necrosis factor-α, epidermal growth factor and transforming growth factor-α on interleukin-8 production by, and human rhinovirus replication in, bronchial epithelial cells , 2001 .

[21]  J. Shelhamer,et al.  Oxidative stress induces arachidonate release from human lung cells through the epithelial growth factor receptor pathway. , 2002, American journal of respiratory cell and molecular biology.

[22]  R. Lefkowitz,et al.  Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathway , 1995, Nature.

[23]  R. Shaykhiev,et al.  Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[24]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[25]  M. Burdick,et al.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.

[26]  J. Romijn,et al.  Interferon‐γ in healthy subjects: selective modulation of inflammatory mediators , 2001, European journal of clinical investigation.

[27]  M. Burdick,et al.  CXC Chemokines: Angiogenesis, Immunoangiostasis, and Metastases in Lung Cancer , 2004, Annals of the New York Academy of Sciences.

[28]  T. Joh,et al.  IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. , 2005, Cytokine.

[29]  Mary E. Choi,et al.  TGF-β1 stimulates HO-1 via the p38 mitogen-activated protein kinase in A549 pulmonary epithelial cells , 2002 .

[30]  D. Ann,et al.  Oxidative Stress Disrupts Glucocorticoid Hormone-dependent Transcription of the Amiloride-sensitive Epithelial Sodium Channel α-Subunit in Lung Epithelial Cells through ERK-dependent and Thioredoxin-sensitive Pathways* , 2000, The Journal of Biological Chemistry.

[31]  H. Harn,et al.  Requirement for ERK activation in acetone extract identified from Bupleurum scorzonerifolium induced A549 tumor cell apoptosis and keratin 8 phosphorylation. , 2005, Life sciences.

[32]  M. Runge,et al.  Thrombin Stimulates Phosphorylation of Insulin-like Growth Factor-1 Receptor, Insulin Receptor Substrate-1, and Phospholipase C-γ1 in Rat Aortic Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[33]  S. Dubinett,et al.  Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[34]  K. Rabe,et al.  Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione , 2005, Respiratory research.

[35]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[36]  B. Milleron,et al.  Upregulation of bronchioloalveolar carcinoma-derived C-X-C chemokines by tumor infiltrating inflammatory cells , 2003, Inflammation Research.

[37]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[38]  M. Matsuoka,et al.  Phosphorylation of p53 protein in A549 human pulmonary epithelial cells exposed to asbestos fibers. , 2002, Environmental health perspectives.

[39]  A. Ullrich,et al.  Distinct ADAM Metalloproteinases Regulate G Protein-coupled Receptor-induced Cell Proliferation and Survival* , 2004, Journal of Biological Chemistry.

[40]  W. D. Boer.  Cytokines and therapy in COPD: A promising combination? , 2002 .

[41]  Lesley Seymour,et al.  Erlotinib in lung cancer - molecular and clinical predictors of outcome. , 2005, The New England journal of medicine.

[42]  K. Rabe,et al.  Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. , 2004, American journal of respiratory cell and molecular biology.

[43]  C. Bucana,et al.  Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. , 1994, Cancer research.

[44]  L. Heasley,et al.  G protein-coupled receptor systems involved in cell growth and oncogenesis. , 1995, Endocrine reviews.

[45]  P. Barbini,et al.  Bronchiolo-alveolar carcinoma: an analysis of survival predictors. , 1992, European journal of cancer.

[46]  L. Trevisani,et al.  Structural characterization of the bronchial epithelium of subjects with chronic bronchitis and in asymptomatic smokers. , 1992, Respiration; international review of thoracic diseases.

[47]  F. Preffer,et al.  Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. , 2004, American journal of respiratory cell and molecular biology.

[48]  J. Bousquet,et al.  Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. , 1994, American journal of respiratory and critical care medicine.

[49]  Apoptosis and cancer chemotherapy. , 2001, Trends in cell biology.

[50]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[51]  M. Sticherling,et al.  Bioactive interleukin-8 is expressed in wounds and enhances wound healing. , 2000, The Journal of surgical research.

[52]  A. Haslberger,et al.  Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation. , 1992, The Journal of investigative dermatology.

[53]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[54]  K. Rabe,et al.  Human neutrophil defensins and secretory leukocyte proteinase inhibitor in squamous metaplastic epithelium of bronchial airways , 2004, Inflammation Research.

[55]  C. Benjamin,et al.  Convergence of Angiotensin II and Platelet-derived Growth Factor Receptor Signaling Cascades in Vascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[56]  W. Schobersberger,et al.  Alveolar granulocyte colony-stimulating factor and alpha-chemokines in relation to serum levels, pulmonary neutrophilia, and severity of lung injury in ARDS. , 2004, Chest.

[57]  K P Offord,et al.  Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. , 1986, Annals of internal medicine.

[58]  R. Strieter,et al.  Chemokines: angiogenesis and metastases in lung cancer. , 2004, Novartis Foundation symposium.

[59]  P. Woll,et al.  Interleukin-8/CXCL8 is a growth factor for human lung cancer cells , 2004, British Journal of Cancer.